The role of the kidney in the quest for the origin of hypoglycemia
Gupta et al. [1] do well in presenting the approach and management
strategy of hypoglycemia, a common clinical setting in primary care
clinic, but I think they can direct more emphasis upon renal dysfunction,
yet another common scenario which dodges our attention. When searching for
the cause of hypoglycemia, the first few ideas that flash through our mind
are usually lifestyle change, missing meals, or appetite change, but a
recent change of renal function rarely pops out in our list of
precipitating factors.
Why should we keep renal dysfunction in our mind? It can be explained
in the following two ways:
First, nephropathy is one of the most dreaded complications of
diabetes mellitus (DM). Earlier studies in 1970s have determined that
32~54% of patients with DM develop nephropathy within 15~20 years [2],
while with the renovation of treatment principle and practice,
microalbuminuria and overt proteinuria still occur in 27~39% and 7~12% of
patients with type II DM after 15 years [3]. The incidence of overt renal
failure is also estimated at roughly one event per 1000 patient-years in
UKPDS (United Kingdom Prospective Diabetes Study) [3]. From this view,
assuming that the patient in vignette has a fair glycemic control, we can
expect he has a 10% possibility of developing proteinuria and 1% risk of
renal failure over 10~15 years of disease. In addition, patients with
diabetic nephropathy [4] and diabetes per se [5] are at risk of developing
acute kidney injury, thus the index patient carries a certain risk of
chronic kidney disease (CKD) and also acute kidney injury (AKI).
Second, glycemic control can be bizarre during period of renal
function deterioration. Moren et al. have demonstrated from a large cohort
of CKD patients that estimated glomerular filtration rate (GFR) less than
60 ml/min per 1.73 square meter is a risk factor for hypoglycemia and
excessive mortality [6]. Similarly, glycemic variability and hypoglycemia
prominently increase during episode of critical patients with AKI [7]. The
evidence for hypoglycemia in renal failure, whether acute or chronic, is
thus abundant and convincing. The precise mechanism may involve impaired
endogenous or exogenous insulin degradation, and delayed excretion of most
oral hypoglycemic agents (OHA). Blunted gluconeogenesis of renal origin
likely plays a role, too.
With all of these issues in mind, we can now return to the real
world: "how often does renal dysfunction occur in the setting of newly
found hypoglycemia episodes?" This is best demonstrated by studies done in
emergency department (ED), since most episodes of hypoglycemia with
altered mental status happen outside of clinics. Sinert et al. have
performed an interesting study in EDs [8], investigating the utility of
routine laboratory testing in hypoglycemia management. They find that
about one-fourth of patients have new onset renal failure while one-third
patients have chronic renal insufficiency, verifying our prediction that
renal dysfunction is a common scenario during a newly found hypoglycemic
attack. There is also report that specifies unexplained hypoglycemia in a
diabetic patient should direct our attention to renal failure [9].
There are still other reasons that we should arrange renal function
test when dealing with hypoglycemia. Impaired renal function could
influence our choice of OHA classes, and also the dosage of insulin.
Patients with diabetic nephropathy are often given angiotensin-converting
enzyme inhibitor or angiotensin receptor blocker for halting disease
progression, and use of these agents have been reported to correlate with
reduced hypoglycemia risk in type II diabetic patients [10]. A clinical
encounter with hypoglycemic patients thus provides an excellent
opportunity for primary care physicians to check-out their patients'
diabetic progression, presence of microvascular complication, and at the
same time to revise their patients' current medication regimen. We may
find an otherwise asymptomatic patient with abnormally high creatinine
level and simultaneously receiving metformin or other potentially
nephrotoxic drugs. This population of patients should not be missed in our
clinics, I believe.
In light of the high percentage of renal dysfunction as precipitant
or contributing factors in hypoglycemia, and the potential benefit of
early detection of renal dysfunction, acute or chronic, I suggest checking
renal function routinely to rid these patients of the potential risk.
Hypoglycemia is, in itself, an opportunity to discover gaps in our
management plan, and we should all grasp this chance tightly and
efficiently.
REFERENCES
1. Gupta PS, Green AN, Chowdhury TA. 10-minute consultation: Hypoglycemia.
BMJ 2011;342:d567
2. Johnsson S. Retinopathy and nephropathy in diabetes mellitus:
Comparison of the effects of two forms of treatment. Diabetes 1960;9:1-8
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-
glucose control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes
(UKPDS 33). Lancet 1998;352:837-53
4. Calvin AD, Misra S, Pflueger A. Contrast-induced acute kidney
injury and diabetic nephropathy. Nat Rev Nephrol 2010;6:679-88
5. Zhang X, Wu Z, Peng X, Wu A, Yue Y, Martin J, et al. Prognosis of
diabetic patients undergoing coronary artery bypass surgery compared with
nondiabetics: a systematic review and meta-analysis. J Cardiothorac Vasc
Anesth 2010,doi:10.1053/j.jvca.2010.09.021
6. Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, et al.
Frequency of hypoglycemia and its significance in chronic kidney disease.
Clin J Am Soc Nephrol 2009;4:1121-7
7. Dickerson RN, Hamilton LA, Connor KA, Maish III GO, Croce MA,
Minard G, et al. Increased hypoglycemia associated with renal failure
during continuous intravenous insulin infusion and specialized nutritional
support. Nutrition 2010, doi:10.1016/j.nut.2010.08.009
8. Sinert R, Su M, Secko M, Zehtabchi S. The utility of routine
laboratory testing in hypoglycaemic emergency department patients. Emerg
Med J 2009;26:28-31
9. Jikki PN. Apparently unexplainable hypoglycemia in a diabetic
patient - clue for renal failure? J Assoc Phys India 2008;56:645
10. Akram K, Pedersen-Bjergaard U, Cartensen B, Borch-Johnsen K,
Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in
insulin-treated type 2 diabetes: a cross-sectional study. Diabet Med
2006;23:750-6
Competing interests:
No competing interests
28 February 2011
Chia-Ter Chao
Nephrologist
Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital
Rapid Response:
The role of the kidney in the quest for the origin of hypoglycemia
Gupta et al. [1] do well in presenting the approach and management
strategy of hypoglycemia, a common clinical setting in primary care
clinic, but I think they can direct more emphasis upon renal dysfunction,
yet another common scenario which dodges our attention. When searching for
the cause of hypoglycemia, the first few ideas that flash through our mind
are usually lifestyle change, missing meals, or appetite change, but a
recent change of renal function rarely pops out in our list of
precipitating factors.
Why should we keep renal dysfunction in our mind? It can be explained
in the following two ways:
First, nephropathy is one of the most dreaded complications of
diabetes mellitus (DM). Earlier studies in 1970s have determined that
32~54% of patients with DM develop nephropathy within 15~20 years [2],
while with the renovation of treatment principle and practice,
microalbuminuria and overt proteinuria still occur in 27~39% and 7~12% of
patients with type II DM after 15 years [3]. The incidence of overt renal
failure is also estimated at roughly one event per 1000 patient-years in
UKPDS (United Kingdom Prospective Diabetes Study) [3]. From this view,
assuming that the patient in vignette has a fair glycemic control, we can
expect he has a 10% possibility of developing proteinuria and 1% risk of
renal failure over 10~15 years of disease. In addition, patients with
diabetic nephropathy [4] and diabetes per se [5] are at risk of developing
acute kidney injury, thus the index patient carries a certain risk of
chronic kidney disease (CKD) and also acute kidney injury (AKI).
Second, glycemic control can be bizarre during period of renal
function deterioration. Moren et al. have demonstrated from a large cohort
of CKD patients that estimated glomerular filtration rate (GFR) less than
60 ml/min per 1.73 square meter is a risk factor for hypoglycemia and
excessive mortality [6]. Similarly, glycemic variability and hypoglycemia
prominently increase during episode of critical patients with AKI [7]. The
evidence for hypoglycemia in renal failure, whether acute or chronic, is
thus abundant and convincing. The precise mechanism may involve impaired
endogenous or exogenous insulin degradation, and delayed excretion of most
oral hypoglycemic agents (OHA). Blunted gluconeogenesis of renal origin
likely plays a role, too.
With all of these issues in mind, we can now return to the real
world: "how often does renal dysfunction occur in the setting of newly
found hypoglycemia episodes?" This is best demonstrated by studies done in
emergency department (ED), since most episodes of hypoglycemia with
altered mental status happen outside of clinics. Sinert et al. have
performed an interesting study in EDs [8], investigating the utility of
routine laboratory testing in hypoglycemia management. They find that
about one-fourth of patients have new onset renal failure while one-third
patients have chronic renal insufficiency, verifying our prediction that
renal dysfunction is a common scenario during a newly found hypoglycemic
attack. There is also report that specifies unexplained hypoglycemia in a
diabetic patient should direct our attention to renal failure [9].
There are still other reasons that we should arrange renal function
test when dealing with hypoglycemia. Impaired renal function could
influence our choice of OHA classes, and also the dosage of insulin.
Patients with diabetic nephropathy are often given angiotensin-converting
enzyme inhibitor or angiotensin receptor blocker for halting disease
progression, and use of these agents have been reported to correlate with
reduced hypoglycemia risk in type II diabetic patients [10]. A clinical
encounter with hypoglycemic patients thus provides an excellent
opportunity for primary care physicians to check-out their patients'
diabetic progression, presence of microvascular complication, and at the
same time to revise their patients' current medication regimen. We may
find an otherwise asymptomatic patient with abnormally high creatinine
level and simultaneously receiving metformin or other potentially
nephrotoxic drugs. This population of patients should not be missed in our
clinics, I believe.
In light of the high percentage of renal dysfunction as precipitant
or contributing factors in hypoglycemia, and the potential benefit of
early detection of renal dysfunction, acute or chronic, I suggest checking
renal function routinely to rid these patients of the potential risk.
Hypoglycemia is, in itself, an opportunity to discover gaps in our
management plan, and we should all grasp this chance tightly and
efficiently.
REFERENCES
1. Gupta PS, Green AN, Chowdhury TA. 10-minute consultation: Hypoglycemia.
BMJ 2011;342:d567
2. Johnsson S. Retinopathy and nephropathy in diabetes mellitus:
Comparison of the effects of two forms of treatment. Diabetes 1960;9:1-8
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-
glucose control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes
(UKPDS 33). Lancet 1998;352:837-53
4. Calvin AD, Misra S, Pflueger A. Contrast-induced acute kidney
injury and diabetic nephropathy. Nat Rev Nephrol 2010;6:679-88
5. Zhang X, Wu Z, Peng X, Wu A, Yue Y, Martin J, et al. Prognosis of
diabetic patients undergoing coronary artery bypass surgery compared with
nondiabetics: a systematic review and meta-analysis. J Cardiothorac Vasc
Anesth 2010,doi:10.1053/j.jvca.2010.09.021
6. Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, et al.
Frequency of hypoglycemia and its significance in chronic kidney disease.
Clin J Am Soc Nephrol 2009;4:1121-7
7. Dickerson RN, Hamilton LA, Connor KA, Maish III GO, Croce MA,
Minard G, et al. Increased hypoglycemia associated with renal failure
during continuous intravenous insulin infusion and specialized nutritional
support. Nutrition 2010, doi:10.1016/j.nut.2010.08.009
8. Sinert R, Su M, Secko M, Zehtabchi S. The utility of routine
laboratory testing in hypoglycaemic emergency department patients. Emerg
Med J 2009;26:28-31
9. Jikki PN. Apparently unexplainable hypoglycemia in a diabetic
patient - clue for renal failure? J Assoc Phys India 2008;56:645
10. Akram K, Pedersen-Bjergaard U, Cartensen B, Borch-Johnsen K,
Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in
insulin-treated type 2 diabetes: a cross-sectional study. Diabet Med
2006;23:750-6
Competing interests: No competing interests